ASM Signs onto a Letter Regarding the 21st Century Cures Initiative and the Antibiotic Development to Advance Patient Treatment (ADAPT) Act
The ASM joined 23 other organizations in signing a letter to the House Energy & Commerce Committee urging them to act promptly on the Antibiotic Development to Advance Patient Treatment (ADAPT) Act, which would carry out the PCAST recommendation to establish a new limited population approval pathway for antibiotics to treat serious or life-threatening infections where an unmet medical need exists.
The ASM has submitted appropriation recommendations for federal agencies that support biomedical and public health research.
The Spring 2014 issue of the CSWM Communicator has been published by the CSWM. It features highlights of the committee's activities at this year asm2014 meeting in Boston, MA.
The content of this page is restricted to ASM Members only.
Please login at the top-right or to become a member, join ASM.
Dr. Timothy Donohue, President Elect of ASM, spoke about microbiology and ASM during the public comment session of the NIGMS Council meeting on January 24, 2014.
Biomedical and Life Sciences Research - Federal Funding for FY 2015
A compilation of the ASM recommendations to Congress for FY 2015 funding for the National Institutes of Health, the Centers for Disease Control and Prevention, the Food and Drug Administration, and science funding in the the National Science Foundation, the Department of Agriculture and the Department of Energy. To read the report go to: http://www.asm.org/images/PSAB/ASM-FF-2015-Final.pdf.